Vimarsana
Biggest News Aggregation in the World

Almirall Enter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Almirall Enter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Almirall Enter Today - Breaking & Trending Today

Ichnos Sciences and Almirall Enter into a Licensing Agreement for First-in-Class IL-1RAP Antagonist Monoclonal Antibody - Vimarsana News

Ichnos Sciences and Almirall Enter into a Licensing Agreement for First-in-Class IL-1RAP Antagonist Monoclonal Antibody

Published: December 15, 2021

Ichnos Sciences and Almirall Enter into a Licensing Agreement for First-in-Class IL-1RAP Antagonist Monoclonal Antibody  ·         Almirall is Granted Exclusive Global Rights to Develop and Commercialize ISB 880 for Use in Autoimmune Diseases NEW YORK, US...

Source: pharmiweb.com
Related Topics:
New YorkUnited StatesComunidad Autonoma De CatalunaCyril KontoKarl ZiegelbauerIchnos Sciences IncIchnos SciencesSpanish Stock ExchangeAlmirall EnterLicensing AgreementGranted Exclusive Global RightsNoble Purpose